PMGC Holdings ELAB
NASDAQ ELAB
$1.60 -0.09 (-5.29%)
As of: Nov 11, 2026 · 10:53 AM EST

PMGC Holdings (ELAB) Accumulated Expenses (2023 - 2024)

Updated

PMGC Holdings (ELAB) reported Accumulated Expenses of $137,567 for Q3 2024, up 237.1% from the prior quarter.

Analysis

PMGC Holdings (ELAB) Accumulated Expenses (2023 - 2024) Analysis & Trends

At the end of FY2023, PMGC Holdings posted Accumulated Expenses of $73,228.

  • Per Business Quant data, the three quarters before Q3 2024 came in at $40,807 (Q2 2024), $133,573 (Q1 2024) and $73,228 (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PMGC Holdings 824,128.53 -47.54 Mn 385,691.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 137,567.00
Jun 30, 2024 40,807.00
Mar 31, 2024 133,573.00
Dec 31, 2023 73,228.00
API Access

PMGC Holdings Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ELAB&period=max&api_key=YOUR_API_KEY